Necrotizing fasciitis

Internal Medicine

Volumn 49, Issue 12, 2010, Pages 1051-1057

  Shimizu, Taro ^a   Tokuda, Yasuharu ^b  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Necrotizing fasciitis; Review

Indexed keywords

AMPICILLIN; C REACTIVE PROTEIN; CARBAPENEM; CEFAZOLIN; CEPHALOSPORIN; CLINDAMYCIN; CREATINE KINASE; DOXYCYCLINE; GLUCOSE; IMMUNOGLOBULIN; METRONIDAZOLE; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; SODIUM; SULTAMICILLIN; TIMENTIN; VANCOMYCIN;

AEROMONAS HYDROPHILA; ALCOHOL ABUSE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BLISTER; BLOOD CLOTTING DISORDER; BLUNT TRAUMA; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DEBRIDEMENT; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; ERYTHEMA; FEVER; FROZEN SECTION; GLUCOSE BLOOD LEVEL; GRAM STAINING; HAND WASHING; HUMAN; HYPOTENSION; IMMUNE DEFICIENCY; INCIDENCE; KIDNEY DISEASE; LEUKOCYTOSIS; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MULTIPLE ORGAN FAILURE; NECROTIZING FASCIITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PROGNOSIS; SEPSIS; SKIN INDURATION; SKIN INJURY; SKIN NECROSIS; SODIUM BLOOD LEVEL; SOFT TISSUE INFECTION; SPLIT THICKNESS SKIN GRAFT; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; SYMPTOMATOLOGY; TACHYCARDIA; TACHYPNEA; VIBRIO VULNIFICUS; WOUND CARE;

ANIMALS; BACTERIAL INFECTIONS; DIABETES COMPLICATIONS; FASCIITIS, NECROTIZING; HUMANS;

EID: 77953967691     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.2964     Document Type: Article

References (80)

1. Jones J. Surgical Memoirs of the War of the Rebellion. In: Investigation upon the nature, causes and treatment of hospital gangrene as it prevailed in the Confederate armies. US Sanitary Commission, New York, NY, 1871: 1861-1865.
2. The Centers for Disease Control and Prevention, 2009. Group A Streptococcal (GAS) disease http://www.cdc.gov/ncidod/dbmd/diseaseinfo/groupastreptococcal_g.htm Severe Streptcoccus pyogenes Infections, United Kingdom, 2003-2004 http://www.cdc.gov/EID/content/14/2/pdfs/202.pdf Superantigens and Streptococcal Toxic Shock Syndrome http://www.cdc.gov/ncidod/EID/vol9no10/030042.htm
3. File TM Jr, Tan JS, DiPersio JR. Group A streptococcal necrotizing fasciitis. Diagnosing and treating the "flesh-eating bacteria syndrome". Cleve Clin J Med 65: 241-249, 1998.
4. Kaul R, McGeer A, Low DE, Green K, Schwartz B. Population- based surveillance for Group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med 103: 18-24, 1997.
5. Made S. Skin and soft tissue infections. Top Emerg Med 25: 117- 122,2003.
6. Horn JR, Danziger LH, Davis RJ. Warfarin-induced skin necrosis: report of four cases. Am J Hosp Pharm 38: 1763-1768, 1981.
7. Wolf D, Ben-Yehuda A, Okon E, Naparstek Y. Nodular vasculitis associated with propylthiouracil therapy. Cutis 49: 253-255, 1992.
8. Fan PC, Chang HN. Hypersensitivity to mosquito bite: a case report. Gaoxiong Yi Xue Ke Xue Za Zhi 11: 420-424, 1995.
9. Perkins JMT, Magee TR, Galland RB. Phlegmasia caerulea dolens and venous gangrene. Br J Surg 83: 10-23, 1996.
10. Singh G, Sinha SK, Adhikary S, Babu KS, Ray P, Khanna SK. Necrotising infections of soft tissues-a clinical profile. Eur J Surg 168: 366-371, 2002.
11. Elliott DC, Kufera JA, Myers RA. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg 224: 672-683, 1996.
12. Kotrappa KS, Bansal RS, Amin NM. Necrotizing fasciitis. Am Fam Physician 53: 1691-1697, 1996.
13. Gonzalez MH. Necrotizing fasciitis and gangrene of the upper extremity. Hand Clin 14: 635-645, 1998.
14. Green RJ, Dafoe DC, Raffin TA. Necrotizing fasciitis. Chest 110: 219-229, 1996.
15. Chapnick EK, Abter EI. Necrotizing soft-tissue infections. Infect Dis Clin North Am 10: 835-855, 1996.
16. Chen JL, Fullerton KE, Flynn NM. Necrotizing fasciitis associated with injection drug use. Clin Infect Dis 33 6-15, 2001.
17. Wall DB, Klein SR, BlackS, de Virgilio C. A simple model to help distinguish necrotizing fasciitis from non-necrotizing soft tissue infection. J Am Coll Surg 191: 227-231, 2000.
18. Bosshardt TL, Henderson VJ, Organ CH Jr. Necrotizing soft-tissue infections. Arch Surg 131: 846-852, 1996.
19. Childers BJ, Potyondy LD, Nachreiner R, et al. Necrotizing fasciitis: a fourteen-year retrospective study of 163 consecutive patients. Am Surg 68: 109-116, 2002.
20. Burget T. Necrotizing fasciitis? The hazards of delay. J R Soc Med 88: 342-343, 1995.
21. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive Group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 269: 384-389, 1993.
22. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 334: 240-245, 1996.
23. Hlady WG, Klontz KC. The epidemiology of Vibrio infections in Florida, 1981-1993. J Infect Dis 173: 1176-1183, 1996.
24. Frazee BW, Fee C, Lynn J, et al. Community-acquired necrotizing soft tissue infections: a review of 122 cases presenting to a single emergency department over 12 years. J Emerg Med 34: 139-146, 2008.
25. McHenry CR, Piotrowski JJ, Petrinic D, Malangoni MA. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 221: 558-563, 1995.
26. Lille ST, Sato TT, Engrav LH, Foy H, Jurkovich GJ. Necrotizing soft tissue infections: obstacles in diagnosis. J Am Coll Surg 182: 7-11, 1996.
27. Rubinstein E, Dehertogh D, Brettman L. Severe necrotizing soft tissue infections: report of 22 cases. Conn Med 59: 67-72, 1995.
28. Fontes RA Jr, Ogilvie CM, Miclau T. Necrotizing soft-tissue infections. J Am Acad Orthop Surg 8: 151-158, 2000.
29. Wong C, Khin L. Clinical relevance of the LRINEC (laboratory risk indicator for necrotizing fasciitis) score for assessment of early necrotizing fasciitis. Crit Care Med 33: 1677, 2005.
30. Wall DB, de Virgilio C, Black S, Klein SR. Objective criteria may asssist in distinguishing necrotizing fasciitis from non-necrotizing soft tissue infection. Am J Surg 179: 17-21, 2000.
31. Majeski JA, Alexander JW. Early diagnosis, nutrition support, and immediate extensive debridement improve survival necrotizing fasiciitis. Am J Surg 145: 785-787, 1983.
32. Wong C, Khin L, Heng K, Tan K, Low C. The LRINEC (laboratory risk indicator for necrotizing fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 32: 1535-1541, 2004.
33. Wang T, Hung CR. Role of tissue oxygen saturation monitoring in diagnosing necrotizing fasciitis of the lower limbs. Ann Emerg Med 44: 222-228, 2004.
34. Wong C, Wang Y. The diagnosis of necrotizing fasciitis. Curr Opin Infect Dis 18: 101-106, 2005.
35. Andreasen TJ, Green SD, Childers BJ. Massive infectious soft tissue injury: diagnosis and management of necrotizing fasciitis and purpura fulminans. Plast Reconstr Surg 107: 1025-1034, 2001.
36. Majeski J, Majeski E. Improved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J 90: 1065-1068, 1997.
37. Yamaoka M, Furusawa K, Uematsu T, Yasuda K. Early evaluation of necrotizing fasciitis with use of CT. J Craniomaxillofac Surg 22: 268-271, 1994.
38. Rahmouni A, Chosidow O, Mathieu D, et al. MR imaging in acute infectious cellulitis. Radiology 192: 493-496, 1994.
39. Fugitt JB, Puckett ML, Quigley MM, Kerr SM. Necrotizing fasciitis. Radiographics 24: 1472-1476, 2004.
40. Schmid MR, Kossmann T, Duewell S. Differentiation of necrotizing fasciitis and cellulitis using MR imaging. AJR Am J Roent- genol 170: 615, 1998.
41. Scully R, Mark E, McNeely W, McNeely B. Case records of the Massachusetts General Hospital. N Engl J Med 331: 1362-1368, 1994.
42. Elliott D, Kufera JA, Myers RA. The microbiology of necrotizing soft tissue infections. Am J Surg 179: 361-366, 2000.
43. Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 85-A: 1454-1460, 2003.
44. Stone DR, Gorbach SL. Necrotizing fasciitis. The changing spectrum. Dermatol Clin 15: 213-220, 1997.
45. Zahar JR, Goveia J, Lesprit P, Brun-Buisson C. Severe soft tissue infections of the extremities in patients admitted to an intensive care unit. Clin Microbiol Infect 11: 79-82, 2005.
46. Qazi SA, Mohammed AA, Saber EI, Mirza SM. Necrotizing fasciitis. Role of early surgical intervention. Saudi Med J 25: 890-894, 2004.
47. Endorf FW, Supple KG, Gamelli RL. The evolving characteristics and care of necrotizing soft-tissue infections. Burns 31: 269-273, 2005.
48. Taviloglu K, Cabioglu N, Cagatay A, et al. Idiopathic necrotizing fasciitis: risk factors and strategies for management. Am Surg 71: 315-320, 2005.
49. Hsiao CT, Weng HH, Yuan YD, Chen CT, Chen IC. Predictors of mortality in patients with necrotizing fasciitis. Am J Emerg Med 26: 170-175, 2008.
50. Seal DV. Necrotizing fasciitis. Curr Opin Infect Dis 14: 127-132, 2001.
51. Fujisawa N, Yamada H, Kohda H, Tadano J. Necrotizing fasciitis caused by Vibrio vulnificus differs from that caused by streptococcal infection. J Infect 36: 313-316, 1998.
52. Cerveny KE, DePaola A, Duckworth DH, Gulig PA. Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice. Infect Immun 70: 6251-6262, 2002.
53. Howard RJ, Lieb S. Soft-tissue infections caused by halophilic marine vibrios. Arch Surg 123: 245-249, 1988.
54. Chiang SR, Chuang YC. Vibrio vulnificus infection: clinical manifestations, pathogenesis, and antimicrobial therapy. J Microbiol Immunol Infect 36: 81-88, 2003.
55. Chuang YC, Yuan CY, Liu CY, Lan CK, Huang AH. Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment. Clin Infect Dis 15: 271-276, 1992.
56. Liu BM, Hsiao CT, Chung KJ, Kung CT, Hung SC, Liu PP. Hemorrhagic bullae represent an ominous sign for cirrhotic patients. J Emerg Med 34: 277-281, 2008.
57. Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with betalactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 18: 1096, 1999.
58. Mulla ZD. Treatment options in the management of necrotising fasciitis caused by Group A Streptococcus. Expert Opin Pharmacother 5: 1695-1700, 2004.
59. Walsh SR, Ferraro MJ, Durand ML. Clindamycin-resistant Strep tococcus pyogenes: report of a case. Diagn Microbiol Infect Dis 49: 223-225, 2004.
60. Dalsgaard A, Frimodt-Moller N, Bruun B, Hoi L, Larsen JL. Clinical manifestations and molecular epidemiology of Vibrio vulnificus infections in Denmark. Eur J Clin Microbiol Infect Dis 15: 227-232, 1996.
61. Tang HJ, Chang MC, Ko WC, Huang KY, Lee CL, Chuang YC. In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus. Antimicrob Agents Chemother 46: 3580-3584, 2002.
62. Liu JW, Lee IK, Tang HJ, et al. Prognostic factors and antibiotics in Vibrio vulnificus septicemia. Arch Intern Med 166: 2117-2123, 2006.
63. Bowdre JH, Poole MD, Oliver JD. Edema and hemoconcentration in mice experimentally infected with Vibrio vulnificus. Infect Immun 32: 1193-1199, 1981.
64. Klontz KC, Lieb S, Schreiber M, Janowski HT, Baldy LM, Gunn RA. Syndromes of Vibrio vulnificus infections. Clinical and epidemiologic features in Florida cases, 1981-1987. Ann Intern Med 109: 318-323, 1988.
65. Norrby-Teglund A, Muller MP, McGeer A, et al. Successful management of severe group A streptococcal soft tissue infection using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a concervative surgical approach. Scand J Infect Dis 37: 166, 2005.
66. Kaul R, McGEER A, Norrby-Teglund A. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome a comparative observational study. Clin Infect dis 28: 800-807, 1998.
67. Barry W, Hudgins L, Donta S, et al. Intravenous immunoglobulin therapy for toxic shock syndrome. J Am Med Assoc 267: 3315- 3316,1992.
68. Young JM. Necrotising fasciitis. Lancet 343: 1426, 1994.
69. Lamothe F, D'Amico P, Ghosen P, et al. Clinical usefulness of intravenous gammaglobulins in group A streptococcal infections: case report and review. Clin Infect Dis 21: 1469-1470, 1995.
70. Cunningham JD, Silver L, Rudikoff D. Necrotizing fasciitis: a plea for early diagnosis and treatment. Mount Sinai J Med 68: 253-261, 2001.
71. Voros D, Pissiotis C, Georgantas D, Katsaragakis S, Antoniou S, Papadimitriou J. Role of early and extensive surgery in the treatment of severe necrotizing soft tissue infection. Br J Surg 80: 1190-1191, 1993.
72. Ward RG, Walsh MS. Necrotizing fasciitis: 10 years' experience in a district general hospital. Br J Surg 78: 488-489, 1991.
73. Bilton BD, Zibari GB, McMillan RW, Aultman DF, Dunn G, McDonald JC. Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am Surg 64: 397-400, 1998.
74. Riseman JF, Zamboni WA, Curtis A, Graham DR, Konrad HR, Ross DS. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery 108: 847- 850,1990.
75. Frota Filho JD, Drews C, Leaes P, et al. Postoperative necrotizing fasciitis of the thorax in cardiac surgery. Arq Bras Cardiol 76: 245-254, 2001.
76. Huang W, Hsieh S, Hsieh C, Schoung J, Huang T. Use of vacuum-assisted wound closure to manage limb wounds in patients suffering from acute necrotizing fasciitis. Asian J Surg 29: 135-139, 2006.
77. Simonart T, Simonart JM, Derdelinckx I, et al. Value of standard laboratory tests for the early recognition of group A β-Hemolytic streptococcal necrotizing fasciitis. Clin Infect Dis 32: e9-e12, 2000.
78. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 13: 818- 829,1985.
79. Yilmazlar T, Ozturk E, Alsoy A, Ozguc H. Necrotizing soft tissue infections: APACHE II score, dissemination, and survival. World J Surg 31: 1858-1862, 2007.
80. Rimailho A, Riou B, Richar C, Auzepy P. Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. J Infect Dis 155: 143-145, 1987.